<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00982397</url>
  </required_header>
  <id_info>
    <org_study_id>PainFree SST</org_study_id>
    <nct_id>NCT00982397</nct_id>
  </id_info>
  <brief_title>Safety and Clinical Performance of the Protecta ICD and CRT-D</brief_title>
  <official_title>The PainFree SST Clinical Study: Clinical Study to Evaluate System Safety and Clinical Performance of the Protecta ICD + CRT-D and to Assess the Capacity of the Protecta Features to Reduce Inappropriate Shocks.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Cardiac Rhythm and Heart Failure</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Cardiac Rhythm and Heart Failure</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is two-fold. In Phase I (Protecta Clinical Study), system
      performance will be evaluated. In Phase II (PainFree SST), the inappropriate shock-free rate
      at one year of subjects implanted with a Medtronic Protecta implantable cardioverter
      defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) will be
      evaluated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The PainFree SST study was a prospective, multicenter clinical trial, which was conducted in
      two consecutive phases. Phase I assessed safety as determined by assessment of delays in
      ventricular fibrillation (VF) arrhythmia detection time using new algorithms. Phase II
      assessed the influence of new algorithms on inappropriate and unnecessary shocks at 1 year of
      follow-up. Subjects enrolled in Phase I continued in Phase II of the study and data from all
      enrolled subjects contributed to the analysis of Phase II objectives. A sub-study of Phase II
      randomized secondary prevention subjects to either 18/24 NID or 30/40 NID in order to assess
      the safety of prolonged detection in these patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Subjects Who Are Inappropriate Shock Free</measure>
    <time_frame>Implant to one year post-implant</time_frame>
    <description>Primary objective of Phase II. Subjects implanted with a VR device will be analyzed separately from subjects implanted with a DR / CRT-D device. An inappropriate shock is a shock delivered by the defibrillator when the patient's heart rhythm was not a tachyarrhythmia, as adjudicated by the independent Episode Review Committee .</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Subjects With Unanticipated Severe Adverse Device Effects (Phase I)</measure>
    <time_frame>Implant to one month post-implant</time_frame>
    <description>In Phase I, only DR-ICD/CRT-D devices were implanted, so that for Phase I objectives there is only 1 arm to report results for.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Phase I Subjects Where the Ventricular Fibrillation (VF) Detection Time With Protecta Features on is no More Than 2 Seconds Longer Than the VF Detection Time With Protecta Features Off</measure>
    <time_frame>At implant</time_frame>
    <description>In Phase I, only DR-ICD/CRT-D devices were implanted, so that for Phase I objectives there is only 1 arm to report results for.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Secondary Prevention Subjects Who Are Syncopal Event Free</measure>
    <time_frame>Implant to one year post-implant</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">2770</enrollment>
  <condition>Tachyarrhythmias</condition>
  <condition>Heart Failure</condition>
  <condition>Ventricular Dysfunction</condition>
  <arm_group>
    <arm_group_label>Single-chamber detetction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients implanted with a Protecta VR-ICD.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dual-chamber detection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients implanted with a Protecta DR-ICD or CRT-D.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Protecta VR-ICD</intervention_name>
    <description>Protecta single-chamber implantable cardioverter defibrillators.</description>
    <arm_group_label>Single-chamber detetction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Protecta DR-ICD or CRT-D</intervention_name>
    <description>Protecta dual-chamber implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators.</description>
    <arm_group_label>Dual-chamber detection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients meeting one of the following criteria can be included in Phase I of the
             study:

               -  Patients indicated (per local indications) for a dual chamber implantable
                  cardioverter defibrillator (DR-ICD)/cardiac resynchronization therapy
                  defibrillator (CRT-D)

               -  Patients undergoing a device replacement or upgrade to DR-ICD or CRT-D and with
                  the protocol required leads (patients must be enrolled prior to implant)

          -  Patients meeting one of the following criteria can be included in Phase II of the
             study:

               -  Patients indicated for a DR-ICD/VR-ICD/CRT-D device and intended to receive a
                  Protecta device

               -  Patients undergoing a DR-ICD/VR-ICD/CRT-D device replacement or an upgrade to a
                  Protecta DR-ICD/VR-ICD or CRT-D

               -  Patients indicated for a DR-ICD/VR-ICD/CRT-D already implanted with a Protecta
                  device and the protocol required leads, who have not yet been discharged after
                  implant

        Exclusion Criteria:

          -  Patients with a mechanical tricuspid heart valve

          -  Patients enrolled or intended to participate in any concurrent drug and/or device
             study, which would confound the results of this trial as determined by Medtronic,
             during the course of this clinical study

          -  Patients with medical conditions that preclude the testing required for all patients
             by the study protocol or that otherwise limit study participation required for all
             patients

          -  Patients with exclusion criteria required by local law (e.g. age, pregnancy, breast
             feeding, etc)

          -  Patients anticipated not being able to complete the study

          -  Patients unwilling to provide written informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>A. Meijer, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Eindhoven, The Netherlands</affiliation>
  </overall_official>
  <overall_official>
    <last_name>A. Auricchio, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lugano, Switzerland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>T. Kurita, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Higashi-Osaka, Japan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>E.J. Schloss, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cincinnati Ohio, USA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>L. Sterns, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Victoria, British Columbia, Canada</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Birmingham Heart Clinic PC</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CardioVasular Associates of Mesa</name>
      <address>
        <city>Mesa</city>
        <state>Arizona</state>
        <zip>85206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Hospital Fort Smith</name>
      <address>
        <city>Fort Smith</city>
        <state>Arkansas</state>
        <zip>72903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LA Cardiology Associates</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Consultants of Napa Valley</name>
      <address>
        <city>Napa</city>
        <state>California</state>
        <zip>94558</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hartford Hospital</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Florida Health at Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arrhythmia Syncope Consultants LLC</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33133</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana Heart Physicians</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46237</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Research of Northwest Indiana</name>
      <address>
        <city>Munster</city>
        <state>Indiana</state>
        <zip>46321</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Iowa Heart Center</name>
      <address>
        <city>West Des Moines</city>
        <state>Iowa</state>
        <zip>50314</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Delmarva Heart Research Foundation</name>
      <address>
        <city>Salisbury</city>
        <state>Maryland</state>
        <zip>21804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Essentia Institute of Rural Health</name>
      <address>
        <city>Duluth</city>
        <state>Minnesota</state>
        <zip>55805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CentraCare Heart &amp; Vascular Center</name>
      <address>
        <city>Saint Cloud</city>
        <state>Minnesota</state>
        <zip>56303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Louis Heart &amp; Vascular PC</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>62040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint John's Medical Research Inc</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology PC</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pinehurst Medical Clinic</name>
      <address>
        <city>Pinehurst</city>
        <state>North Carolina</state>
        <zip>28374</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ohio Heart and Vascular</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincent Mercy Medical Center</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Bucks Cardiology</name>
      <address>
        <city>Doylestown</city>
        <state>Pennsylvania</state>
        <zip>18901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pee Dee Cardiology</name>
      <address>
        <city>Florence</city>
        <state>South Carolina</state>
        <zip>29506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Consultants PA</name>
      <address>
        <city>Spartanburg</city>
        <state>South Carolina</state>
        <zip>29303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centennial Heart Cardiovascular Consultants LLC</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hall-Garcia Cardiology Associates</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University Health System</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spokane Cardiology</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia St. Mary's Hospital</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LKH - Universitätsklinikum Graz</name>
      <address>
        <city>Graz</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Landesklinikum St. Pölten</name>
      <address>
        <city>St. Polten</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Wels-Grieskirchen GmbH</name>
      <address>
        <city>Wels</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Paul's Hospital (Vancouver BC)</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Jubilee Hospital</name>
      <address>
        <city>Victoria</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Universitaire de Cardiologieet de Pneumologie de Québec (IUCPQ)</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Newmarket Electrophysiology Research Group</name>
      <address>
        <city>Newmarket</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth II Health Sciences Centre</name>
      <address>
        <city>Halifax</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kelowna Arrhythmia Research</name>
      <address>
        <city>Kelowna</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen's University &amp; Kingston General Hospital</name>
      <address>
        <city>Kingston</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Centre - University Campus</name>
      <address>
        <city>London</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montreal Heart Institute</name>
      <address>
        <city>Montreal</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Ottawa Heart Institute</name>
      <address>
        <city>Ottawa</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fundacion Cardioinfantil</name>
      <address>
        <city>Bogota</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Cardiovascular del Nino</name>
      <address>
        <city>Bogota</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica Cardiovascular Santa Maria</name>
      <address>
        <city>Medellin</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krajska nemocnice Liberec a.s. - Kardiocentrum</name>
      <address>
        <city>Liberec</city>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aalborg Sygehus</name>
      <address>
        <city>Aalborg</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aarhus Universitetshospital - Skejby</name>
      <address>
        <city>Aarhus</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herz- und Gefässzentrum Bad Bevensen</name>
      <address>
        <city>Bad Bevensen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herz- und Diabeteszentrum NRW - Ruhr-Universität Bochum</name>
      <address>
        <city>Bad Oeynhausen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Segeberger Kliniken GmbH</name>
      <address>
        <city>Bad Segeberg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Berufsgenossenschaftliche Universitätsklinik Bergmannsheil GmbH</name>
      <address>
        <city>Bochum</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Bonn</name>
      <address>
        <city>Bonn</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MVZ am Küchwald GmbH ambulantes Herz Zentrum Chemnitz</name>
      <address>
        <city>Chemnitz</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Coburg GmbH</name>
      <address>
        <city>Coburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiocentrum Frankfurt an der Klinik Rotes Kreuz</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Göttingen Georg-August-Universität</name>
      <address>
        <city>Gottingen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ruprecht-Karls-Universität</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Westpfalz-Klinikum GmbH - Standort I Kaiserslautern</name>
      <address>
        <city>Kaiserslautern</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herz Zentrum Bodensee</name>
      <address>
        <city>Konstanz</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Ludwigsburg - Akademisches Lehrkrankenhaus der Universität Heidelberg</name>
      <address>
        <city>Ludwigsburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin der Johannes Gutenberg-Universität Mainz</name>
      <address>
        <city>Mainz</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Städtische Kliniken München GmbH - Klinikum Bogenhausen</name>
      <address>
        <city>Munchen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Städtische Kliniken Neuss Lukaskrankenhaus GmbH-Akad.Lehrkrankenhaus d. Heinrich-Heine-Universität</name>
      <address>
        <city>Neuss</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Rostock</name>
      <address>
        <city>Rostock</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herz- und Kreislaufzentrum Rotenburg a.d. Fulda GmbH</name>
      <address>
        <city>Rotenburg a.d. Fulda</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asklepios Kliniken Schwalm - Eder GmbH - Klinikum Schwalmstadt</name>
      <address>
        <city>Schwalmstadt</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heinrich-Braun-Klinikum Zwickau gemeinnützige GmbH</name>
      <address>
        <city>Zwickau</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Care Institute of Medical Sciences</name>
      <address>
        <city>Ahmedabad</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medanta-The Medicity</name>
      <address>
        <city>Gurgaon</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barzilai Medical Center Ashkelon</name>
      <address>
        <city>Ashkelon</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Soroka University Medical Center</name>
      <address>
        <city>Be'er Sheba</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carmel Medical Center</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rambam Health Care Campus</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shaare Zedek Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rabin Medical Center - Beilinson Hospital</name>
      <address>
        <city>Petach Tikva</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chaim Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaplan Medical Center</name>
      <address>
        <city>Rehovot</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tel Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale classificato ed equiparato Sacro Cuore - Don Calabria</name>
      <address>
        <city>Negrar</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Complesso Ospedaliero San Filippo Neri - Ospedale San Filippo Neri</name>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hirosaki University School of Medicine &amp; Hospital</name>
      <address>
        <city>Hirosaki</city>
        <state>Aomori</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kansai Rosai Hospital</name>
      <address>
        <city>Amagasak</city>
        <state>Hyogo</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kobe University Hospital</name>
      <address>
        <city>Kobe</city>
        <state>Hyogo</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Marianna University School of Medicine Hospital</name>
      <address>
        <city>Kawasaki</city>
        <state>Kanagawa</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinki University Hospital</name>
      <address>
        <city>Osakasaya</city>
        <state>Osaka</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Cerebral and Cardiovasuclar Center</name>
      <address>
        <city>Suita</city>
        <state>Osaka</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sapporo Medical Center NTT EC</name>
      <address>
        <city>Chuo-ku</city>
        <state>Sapporo</state>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Akita Medical Center</name>
      <address>
        <city>Akita</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chiba University Hospital</name>
      <address>
        <city>Chiba</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kokura Memorial Hospital</name>
      <address>
        <city>Kitakyushu</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kumamoto University Hospital</name>
      <address>
        <city>Kumamoto</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyoto University Hospital</name>
      <address>
        <city>Kyoto</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Niigata University Medical &amp; Dental Hospital</name>
      <address>
        <city>Niigata</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kitasato University Hospital</name>
      <address>
        <city>Sagamihara</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Jantung Negara - National Heart Institute</name>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medisch Centrum Alkmaar</name>
      <address>
        <city>Alkmaar</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Academisch Medisch Centrum (AMC)</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Amphia Ziekenhuis - Locatie Molengracht Breda</name>
      <address>
        <city>Breda</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Catharina Ziekenhuis</name>
      <address>
        <city>Eindhoven</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medisch Spectrum Twente</name>
      <address>
        <city>Enschede</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medisch Centrum Leeuwarden</name>
      <address>
        <city>Leeuwarden</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leids Universitair Medisch Centrum</name>
      <address>
        <city>Leiden</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Antonius Ziekenhuis</name>
      <address>
        <city>Nieuwegein</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitair Medisch Centrum Utrecht</name>
      <address>
        <city>Utrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King Faisal Specialist Hospital &amp; Research Center</name>
      <address>
        <city>Riyadh</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prince Salman Heart Centre - King Fahad Medical City</name>
      <address>
        <city>Riyadh</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Centre Ljubljana</name>
      <address>
        <city>Ljubljana</city>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Milpark Hospital</name>
      <address>
        <city>Johannesburg</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital De Cruces</name>
      <address>
        <city>Barakaldo</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Puerta de Hierro Majadahonda</name>
      <address>
        <city>Majadahonda</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Universitario de Vigo (CHUVI) - Hospital del Meixoeiro</name>
      <address>
        <city>Vigo</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitetssjukhuset i Lund</name>
      <address>
        <city>Lund</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Capio S:t Görans Sjukhus</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitetssjukhuset Örebro</name>
      <address>
        <city>Örebro</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardio Centro Ticino</name>
      <address>
        <city>Lugano</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sheikh Khalifa Medical Center</name>
      <address>
        <city>Abu Dhabi</city>
        <country>United Arab Emirates</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Bournemouth Hospital</name>
      <address>
        <city>Bournemouth</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Liverpool Heart and Chest Hospital NHS Foundation Trust</name>
      <address>
        <city>Liverpool</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King's College Hospital NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southampton General Hospital - University Hospital Southampton NHS Foundation Trust</name>
      <address>
        <city>Southampton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Canada</country>
    <country>Colombia</country>
    <country>Czechia</country>
    <country>Denmark</country>
    <country>Germany</country>
    <country>India</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Malaysia</country>
    <country>Netherlands</country>
    <country>Saudi Arabia</country>
    <country>Slovenia</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>United Arab Emirates</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Chile</country>
    <country>Czech Republic</country>
    <country>Finland</country>
    <country>Puerto Rico</country>
  </removed_countries>
  <reference>
    <citation>Auricchio A, Meijer A, Kurita T, Schloss E, Brinkman K, Claessens-van Ooijen M, Sterns L. Safety, efficacy, and performance of new discrimination algorithms to reduce inappropriate and unnecessary shocks: the PainFree SST clinical study design. Europace. 2011 Oct;13(10):1484-93. doi: 10.1093/europace/eur133. Epub 2011 Jun 13.</citation>
    <PMID>21669960</PMID>
  </reference>
  <results_reference>
    <citation>Auricchio A, Schloss EJ, Kurita T, Meijer A, Gerritse B, Zweibel S, AlSmadi FM, Leng CT, Sterns LD; PainFree SST Investigators. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results. Heart Rhythm. 2015 May;12(5):926-36. doi: 10.1016/j.hrthm.2015.01.017. Epub 2015 Jan 28.</citation>
    <PMID>25637563</PMID>
  </results_reference>
  <results_reference>
    <citation>Sterns LD, Meine M, Kurita T, Meijer A, Auricchio A, Ando K, Leng CT, Okumura K, Sapp JL, Brown ML, Lexcen DR, Gerritse B, Schloss EJ. Extended detection time to reduce shocks is safe in secondary prevention patients: The secondary prevention substudy of PainFree SST. Heart Rhythm. 2016 Jul;13(7):1489-96. doi: 10.1016/j.hrthm.2016.03.022. Epub 2016 Mar 14.</citation>
    <PMID>26988379</PMID>
  </results_reference>
  <results_reference>
    <citation>Wollmann CG, Lawo T, Kühlkamp V, Becker R, Garutti C, Jackson T, Brown ML, Mayr H. Implantable defibrillators with enhanced detection algorithms: detection performance and safety results from the PainFree SST study. Pacing Clin Electrophysiol. 2014 Sep;37(9):1198-209. doi: 10.1111/pace.12390. Epub 2014 Mar 25.</citation>
    <PMID>24665992</PMID>
  </results_reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 22, 2009</study_first_submitted>
  <study_first_submitted_qc>September 22, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2009</study_first_posted>
  <results_first_submitted>May 25, 2016</results_first_submitted>
  <results_first_submitted_qc>October 5, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">November 6, 2017</results_first_posted>
  <last_update_submitted>October 5, 2017</last_update_submitted>
  <last_update_submitted_qc>October 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Ventricular Dysfunction</mesh_term>
    <mesh_term>Tachycardia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Twenty patients were excluded from analysis, because they did not meet the eligibility criteria; 1 patient did not sign consent, 1 patient participated in a confounding trial, 8 patients did not have an implant attempted, 5 patients failed implant, and 5 patients received a device other than the Protecta.Total enrolled=2790, total analyzed=2770</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>DR-ICD/CRT-D</title>
          <description>Patients implanted with a dual-chamber ICD (DR-ICD) or cardiac resynchronization therapy defibrillator (CRT-D).</description>
        </group>
        <group group_id="P2">
          <title>VR-ICD</title>
          <description>Patients implanted with a single-chamber ICD (VR-ICD).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Phase I</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="236"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="236"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Phase II/Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2019"/>
                <participants group_id="P2" count="751"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Secondary Prevention Randomized 18/24NID</title>
              <participants_list>
                <participants group_id="P1" count="231"/>
                <participants group_id="P2" count="122"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Secondary Prevention Randomized 30/40NID</title>
              <participants_list>
                <participants group_id="P1" count="221"/>
                <participants group_id="P2" count="131"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2019"/>
                <participants group_id="P2" count="751"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>DR-ICD/CRT-D</title>
          <description>Patients implanted with a dual-chamber ICD (DR-ICD) or cardiac resynchronization therapy defibrillator (CRT-D).</description>
        </group>
        <group group_id="B2">
          <title>VR-ICD</title>
          <description>Patients implanted with a single-chamber ICD (VR-ICD).</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2019"/>
            <count group_id="B2" value="751"/>
            <count group_id="B3" value="2770"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.9" spread="12.1"/>
                    <measurement group_id="B2" value="61.9" spread="12.1"/>
                    <measurement group_id="B3" value="64.8" spread="12.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="430"/>
                    <measurement group_id="B2" value="140"/>
                    <measurement group_id="B3" value="570"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1589"/>
                    <measurement group_id="B2" value="611"/>
                    <measurement group_id="B3" value="2200"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Austria</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="119"/>
                    <measurement group_id="B2" value="145"/>
                    <measurement group_id="B3" value="264"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Colombia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Czech Republic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Denmark</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="248"/>
                    <measurement group_id="B2" value="57"/>
                    <measurement group_id="B3" value="305"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>India</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Israel</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="104"/>
                    <measurement group_id="B2" value="58"/>
                    <measurement group_id="B3" value="162"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Japan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="144"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="181"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Malaysia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Netherlands</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="154"/>
                    <measurement group_id="B2" value="86"/>
                    <measurement group_id="B3" value="240"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Saudi Arabia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="121"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="164"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Slovenia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>South Africa</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Spain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sweden</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Switzerland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United Arab Emirates</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="103"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="114"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="709"/>
                    <measurement group_id="B2" value="156"/>
                    <measurement group_id="B3" value="865"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>LVEF</title>
          <units>%</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.8" spread="13.0"/>
                    <measurement group_id="B2" value="33.3" spread="13.5"/>
                    <measurement group_id="B3" value="32.2" spread="13.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>QRS</title>
          <units>ms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="133.7" spread="33.7"/>
                    <measurement group_id="B2" value="107.1" spread="21.9"/>
                    <measurement group_id="B3" value="125.9" spread="33.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Indication</title>
          <description>Primary prevention is an ICD indication to prevent sudden cardiac death. It refers to use of ICDs in individuals who are at risk for, but have not yet had, an episode of sustained VT, VF, or cardiac arrest.
Secondary prevention refers to an ICD indication for patients who have survived 1 or more cardiac arrests or sustained ventricular tachycardia. Patients with cardiac conditions associated with a high risk of sudden death who have unexplained syncope that is likely to be due to self-terminating ventricular arrhythmias are also considered to have a secondary prevention indication.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Secondary Prevention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="593"/>
                    <measurement group_id="B2" value="254"/>
                    <measurement group_id="B3" value="847"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Primary Prevention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1426"/>
                    <measurement group_id="B2" value="497"/>
                    <measurement group_id="B3" value="1923"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Heart Failure Status</title>
          <description>NYHA Class I-No limitation of physical activity. NYHA Class II-Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).
NYHA Class III-Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.
NYHA Class IV-Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>NYHA I</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="232"/>
                    <measurement group_id="B2" value="187"/>
                    <measurement group_id="B3" value="419"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NYHA II</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="758"/>
                    <measurement group_id="B2" value="346"/>
                    <measurement group_id="B3" value="1104"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NYHA III</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="754"/>
                    <measurement group_id="B2" value="99"/>
                    <measurement group_id="B3" value="853"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NYHA IV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No Heart Failure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="245"/>
                    <measurement group_id="B2" value="109"/>
                    <measurement group_id="B3" value="354"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Subjects Who Are Inappropriate Shock Free</title>
        <description>Primary objective of Phase II. Subjects implanted with a VR device will be analyzed separately from subjects implanted with a DR / CRT-D device. An inappropriate shock is a shock delivered by the defibrillator when the patient's heart rhythm was not a tachyarrhythmia, as adjudicated by the independent Episode Review Committee .</description>
        <time_frame>Implant to one year post-implant</time_frame>
        <group_list>
          <group group_id="O1">
            <title>DR-ICD/CRT-D</title>
            <description>Patients implanted with a dual-chamber ICD (DR-ICD) or cardiac resynchronization therapy defibrillator (CRT-D).</description>
          </group>
          <group group_id="O2">
            <title>VR-ICD</title>
            <description>Patients implanted with a single-chamber ICD (VR-ICD).</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects Who Are Inappropriate Shock Free</title>
          <description>Primary objective of Phase II. Subjects implanted with a VR device will be analyzed separately from subjects implanted with a DR / CRT-D device. An inappropriate shock is a shock delivered by the defibrillator when the patient's heart rhythm was not a tachyarrhythmia, as adjudicated by the independent Episode Review Committee .</description>
          <units>percentage of patients</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2019"/>
                <count group_id="O2" value="751"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.5" lower_limit="97.9" upper_limit="99.0"/>
                    <measurement group_id="O2" value="97.5" lower_limit="96.1" upper_limit="98.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>The study was designed to include at least 1,131 patients with DR/CRT-D ICD devices in order to estimate the inappropriate shock free rate at 1 year post-implant with 1% precision.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>percentage of participants</param_type>
            <param_value>98.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>97.9</ci_lower_limit>
            <ci_upper_limit>99.0</ci_upper_limit>
            <estimate_desc>Therapy rates were analyzed using competing risks survival analysis methods, accounting for death as a competing risk.Therapy incidence rates were estimated using cumulative incidence functions and reported with 95% confidence interval.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This study was designed to include at least 610 patients with VR-ICD devices in order to estimate the inappropriate shock free rate at 1 year post-implant with a precision of 2%.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>percentage of participants</param_type>
            <param_value>97.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>96.1</ci_lower_limit>
            <ci_upper_limit>98.5</ci_upper_limit>
            <estimate_desc>Therapy rates were analyzed using competing risks survival analysis methods, accounting for death as a competing risk.Therapy incidence rates were estimated using cumulative incidence functions and reported with 95% confidence interval.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Subjects With Unanticipated Severe Adverse Device Effects (Phase I)</title>
        <description>In Phase I, only DR-ICD/CRT-D devices were implanted, so that for Phase I objectives there is only 1 arm to report results for.</description>
        <time_frame>Implant to one month post-implant</time_frame>
        <population>Phase I subjects (a subset of the total number of subjects) implanted with a Protecta device with at least 30 days of follow-up or a USADE within the first 30 days post-implant are included in this analysis. One hundred subjects met the criteria above and are included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase I</title>
            <description>Subjects enrolled in Phase I of the study (Protecta).</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects With Unanticipated Severe Adverse Device Effects (Phase I)</title>
          <description>In Phase I, only DR-ICD/CRT-D devices were implanted, so that for Phase I objectives there is only 1 arm to report results for.</description>
          <population>Phase I subjects (a subset of the total number of subjects) implanted with a Protecta device with at least 30 days of follow-up or a USADE within the first 30 days post-implant are included in this analysis. One hundred subjects met the criteria above and are included in the analysis.</population>
          <units>percentage of patients</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" upper_limit="3.0">As specified in the protocol and analysis plan, only a one-sided 95% binomial upper confidence bound is used.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Using the one-sided one proportion Exact Test in PASS sample size software, a sample size of 76 subjects with 1-month follow-up was calculated to be required for the evaluation of this objective. To ensure adequate testing of the Protecta XT CRT-D device, the 76 subjects must have included at least 34 CRT-D subjects. Assuming an attrition rate of 10%, a sample size of 85 subjects enrolled was calculated to be required.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>P-value is for comparison against a performance criterion of 10%.</p_value_desc>
            <method>Exact Binomial</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Phase I Subjects Where the Ventricular Fibrillation (VF) Detection Time With Protecta Features on is no More Than 2 Seconds Longer Than the VF Detection Time With Protecta Features Off</title>
        <description>In Phase I, only DR-ICD/CRT-D devices were implanted, so that for Phase I objectives there is only 1 arm to report results for.</description>
        <time_frame>At implant</time_frame>
        <population>Of the 236 subjects implanted, 40 subjects / episodes were classified as not useable. In Phase I, only DR-ICD/CRT-D devices were implanted, so that for Phase I objectives there is only 1 arm to report results for.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase I</title>
            <description>Subjects enrolled in Phase I of the study (Protecta).</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Phase I Subjects Where the Ventricular Fibrillation (VF) Detection Time With Protecta Features on is no More Than 2 Seconds Longer Than the VF Detection Time With Protecta Features Off</title>
          <description>In Phase I, only DR-ICD/CRT-D devices were implanted, so that for Phase I objectives there is only 1 arm to report results for.</description>
          <population>Of the 236 subjects implanted, 40 subjects / episodes were classified as not useable. In Phase I, only DR-ICD/CRT-D devices were implanted, so that for Phase I objectives there is only 1 arm to report results for.</population>
          <units>percentage of patients</units>
          <param>Number</param>
          <dispersion>97.5% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="196"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="98.1">As specified in the protocol and analysis plan, a one-side lower confidence bound was used.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>P, the expected proportion of successes under the null hypothesis, was 95%. α, the Type I error rate, is 0.025. Power is 90%. Pa, the assumed true proportion of successes, is 99%. Based on the above assumptions, at least 173 subjects with a useable time to VF detection testing were required for this objective. Assuming a 5% rate for the potential non-adherence to the testing protocol, the required enrollment sample size was 183.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>P-value is for comparison of the observed proportion of successes against a protocol-specified performance criterion of 95%.</p_value_desc>
            <method>Confidence interval and hypothesis test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Secondary Prevention Subjects Who Are Syncopal Event Free</title>
        <time_frame>Implant to one year post-implant</time_frame>
        <population>Includes randomized secondary prevention patients from Phase II.</population>
        <group_list>
          <group group_id="O1">
            <title>18/24 NID</title>
            <description>Secondary prevention subjects in Phase II randomized to 18/24 NID. (18/24 NID indicates the number of intervals used to detect VF was programmed to 18 of 24 intervals).</description>
          </group>
          <group group_id="O2">
            <title>30/40 NID</title>
            <description>Secondary prevention subjects in Phase II randomized to 30/40 NID. (30/40 NID indicates the number of intervals used to detect VF was programmed to 30 of 40 intervals).</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Secondary Prevention Subjects Who Are Syncopal Event Free</title>
          <population>Includes randomized secondary prevention patients from Phase II.</population>
          <units>percentage of patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="353"/>
                <count group_id="O2" value="352"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96"/>
                    <measurement group_id="O2" value="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The expected syncopal event free rate was 0.984 in both programming groups. alpha, Type I error was 0.05. Power, 1-beta, was 80%. Non-inferiority margin 5% Based on the above assumptions and Farrington-Manning test, a total of 230 subjects was required. By further assuming 15% attrition rate and 5 % of crossover rate, a total of 300 subjects were needed.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Ho: p1 ≤ p2 - 0.05 Ha: p1 &gt; p2 - 0.05 Where p1 was the syncopal event free rate at one year post implant by programming VF NID 30/40 and p2 for NID = 18/24. If the null-hypothesis was rejected it was concluded that NID = 30/40 did not decrease the syncope free rate by more than 5% compared to NID = 18/24 and hence was non-inferior.</non_inferiority_desc>
            <p_value>0.0013</p_value>
            <p_value_desc>P-Value is for non-inferiority</p_value_desc>
            <method>Farrington-Manning</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>0.0</param_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.7</ci_lower_limit>
            <ci_upper_limit>2.7</ci_upper_limit>
            <estimate_desc>The 90% Confidence Interval is for the difference (p1-p2), where p1=syncope free rate 30/40 arm and p2=syncope free rate 18/24 arm. Estimated value and confidence interval reflect percentages.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Reported Serious Adverse Events (SAEs) include events starting on or after the date of consent and through study completion, an average of 22 months.</time_frame>
      <desc>Other (non-serious) AE data were not collected for this study.</desc>
      <group_list>
        <group group_id="E1">
          <title>DR-ICD/CRT-D</title>
          <description>Patients implanted with a dual-chamber ICD (DR-ICD) or cardiac resynchronization therapy defibrillator (CRT-D).</description>
        </group>
        <group group_id="E2">
          <title>VR-ICD</title>
          <description>Patients implanted with a single-chamber ICD (VR-ICD).</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (14.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="452" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="125" subjects_at_risk="751"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Anaemia of malignant disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Spontaneous haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Arrhythmia supraventricular</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis coronary artery</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="33" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Atrial tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" subjects_affected="108" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="29" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Cardiac failure acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Cardiac failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Cardiac perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Coronary artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Heart valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Hypertrophic cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Mitral valve disease mixed</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Mitral valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Pulseless electrical activity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Torsade de pointes</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Ventricular arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Ventricular tachyarrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="40" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="751"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial septal defect</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperparathyroidism tertiary</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Retinopathy proliferative</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Abdominal wall haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Colitis ischaemic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Colonic polyp</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Polyp colorectal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Adverse drug reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Catheter site haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Device battery issue</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Device capturing issue</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" subjects_affected="32" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Device electrical impedance issue</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Device extrusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Device failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Device issue</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Device lead damage</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Device lead issue</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Device malfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Device misuse</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Device pacing issue</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Device stimulation issue</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>General physical health deterioration</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Hypothermia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Impaired healing</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Implant site haematoma</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Implant site pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Oversensing</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Sudden cardiac death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Undersensing</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <description>Details not available.</description>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="751"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Hepatic haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Liver disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Arthritis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Arthritis infective</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Bronchitis viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Endocarditis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Implant site abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Implant site infection</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Orchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Pleural infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Pneumococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Pneumonia primary atypical</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Post procedural infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Tuberculosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Cardiac vein dissection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Clavicle fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>In-stent arterial restenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>In-stent coronary artery restenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Multiple injuries</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Pocket erosion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Skull fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Spinal fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Subcutaneous haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Vascular pseudoaneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Wound secretion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Arteriogram coronary</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Blood pressure abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Catheterisation cardiac</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Colonoscopy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Investigation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Liver function test abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Diabetic foot</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Colon adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Gastrointestinal carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Hepatic neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Hepatic neoplasm malignant non-resectable</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Intracranial meningioma malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Myeloid leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Myeloproliferative disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's lymphoma stage IV</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Rectosigmoid cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Renal cancer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Seminoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Transitional cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Cerebrovascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Cognitive disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Hypokinesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Hypotonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Alcohol abuse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Psychotic disorder due to a general medical condition</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Nephritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Renal infarct</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Postmenopausal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Rectocele</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Brain hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Bronchitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Epiglottis ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Hiccups</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Pulmonary congestion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Pulmonary hypertension</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Respiratory acidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Vocal cord polyp</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Adrenalectomy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Cardiac ablation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Central venous catheter removal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Corneal transplant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Coronary artery bypass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Gastrectomy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Heart transplant</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>High frequency ablation</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Hip arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Hospitalisation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Indwelling catheter management</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Knee arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Medical device change</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Medical device implantation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Neurostimulator implantation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Radiotherapy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Toe amputation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Transurethral bladder resection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Urethral repair</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Vertebra dislocation reduction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Vertebroplasty</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Arterial occlusive disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Artery dissection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Embolism arterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Femoral artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Hypovolaemic shock</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Iliac artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Leriche syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Subclavian vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Vasculitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="751"/>
              </event>
              <event>
                <sub_title>Venous thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2019"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="751"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>In most cases, contracts allow investigators (&quot;PI&quot;) to publish per the publication strategy/Clinical Investigation Plan following Medtronic's review for (a) disclosure of confidential information (&quot;CI&quot;), and (b) selection and order of publications by the publications committee. Any such CI is deleted prior to publication/presentation. Medtronic may not otherwise censor/interfere with the publication. PIs may not publish single-site data until the main multi-site publication has occurred.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>CRHF Clinical Research</name_or_title>
      <organization>Medtronic, plc</organization>
      <phone>800-328-2518</phone>
      <email>medtroniccrmtrials@medtronic.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

